116
Participants
Start Date
November 22, 2023
Primary Completion Date
May 22, 2024
Study Completion Date
November 22, 2024
(N1, N3-bis(2- mercaptoethyl)isophthalamide)
600mg / day NBMI treatment for 14 days, administered as four capsules of 100 mg of NBMI every 24 hours, at the start of treatment, the principal investigator or his delegate will verify the intake of the first dose and deliver a blister pack corresponding to the remaining NBMI capsules, at visit day 14 research subjects will be asked to return the packaging with the remaining capsules or not, in order to estimate adherence to treatment.
Excipients microcrystalline cellulose, silica and magnesium stearate
6 Capsules will be administered every 24 hours for 14 days.
RECRUITING
Clínica de la Costa Ltda., Barranquilla
Lead Sponsor
EmeraMed
INDUSTRY